First Turn Management »

Dex shares owned by First Turn Management

Quarter-by-quarter ownership of Dex (DXCM) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Dex

Tip: Access up to 7 years of quarterly data

All positions including Dex held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dex by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $27M 193k 138.70
2023-12-31 $24M 193k 124.09

More positions owned by First Turn Management

Shockwave Med (SWAV)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics (AXSM)
Dex (DXCM)
Immunocore Hldgs Ads (IMCR)
Apogee Therapeutics (APGE)
Vertex Pharmaceuticals Incorporated (VRTX)
Mirum Pharmaceuticals (MIRM)
Biohaven (BHVN)
Krystal Biotech (KRYS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Transmedics Group (TMDX)

View all positions for First Turn Management

Top funds holding Dex

Vanguard Group
BlackRock
Baillie Gifford & Co
Sands Capital Management
FMR
Geode Capital Management
Nuveen Asset Management
Artisan Partners Limited Partnership
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
American Century Companies
Morgan Stanley
William Blair $ Company
Ubs Global Asset Management Americas
Bank of New York Mellon

View all funds holding Dex